Legal status · United Kingdom
Is Triptorelin legal in the United Kingdom?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
Yes. Triptorelin is an approved medicine in the United Kingdom, classified as "Licensed, prescription only (MHRA)". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. On the evidence, 4 human studies are cited on its profile.
Triptorelin in the United Kingdom at a glance
| Classification | Licensed, prescription only (MHRA) |
|---|---|
| Note | Licensed as Decapeptyl SR, with a broader indication set than the United States that includes endometriosis and uterine fibroids alongside prostate cancer and precocious puberty. |
| MHRA approval status | Approved by MHRA for its labeled use |
| Human studies cited | 4 of 4 citations on the profile |
| Reviewed | Sep 2026 |
Classification and note come from the Triptorelin profile, checked against Medicines and Healthcare products Regulatory Agency (MHRA) listings at the reviewed date.
What this means
- 01
MHRA has approved Triptorelin for at least one labeled indication, so a pharmaceutical-grade product exists in the United Kingdom and is dispensed on prescription.
- 02
Approval is indication-specific. Uses outside the label are a clinical decision for a prescriber, not something the approval itself authorizes.
- 03
Unlicensed online vials, including those labeled "research use only", are not the approved product and are not covered by the approval.
What Triptorelin is
A decapeptide GnRH agonist approved in the United States in 2000 for advanced prostate cancer and in 2017 for central precocious puberty. In a pooled analysis of 920 men, 91 to 93 percent held testosterone below 20 ng/dL from month 3 onward. It causes a testosterone flare in the first days of treatment, which is the clinical reason the antagonists exist.
Triptorelin is a synthetic ten-amino-acid analogue of gonadotrophin-releasing hormone, the hypothalamic signal that drives the pituitary to release luteinising hormone and follicle-stimulating hormone. It is an agonist, which sounds like it should raise sex hormones and briefly does, before shutting the axis down.
Mechanism: Continuous rather than pulsatile occupancy of the GnRH receptor on pituitary gonadotrophs. Physiological GnRH arrives in pulses, and the receptor requires that rhythm to keep signalling.
Regulatory history: FDA-approved. Trelstar under NDA 020715 on 15 June 2000 for palliative treatment of advanced prostate cancer, with additional formulations approved in 2001 and 2010. Triptodur under NDA 208956 on 29 June 2017 for central precocious puberty in children aged two and older. Not approved in the United States for endometriosis, for fertility protocols, or for any use in healthy adults.
How MHRA treats this kind of product
Licenses medicines for the UK market. A compound without a marketing authorisation is an unlicensed medicine, which can only lawfully be supplied for human use through a prescriber under the specials scheme, not sold as a research product.
The classification above is the The Longevity Archive reading of Medicines and Healthcare products Regulatory Agency listings for Triptorelin at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Triptorelin in other countries
Frequently asked questions
Is Triptorelin legal in the United Kingdom?
Yes. Triptorelin is an approved medicine in the United Kingdom, classified as "Licensed, prescription only (MHRA)". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. On the evidence, 4 human studies are cited on its profile. Note: Licensed as Decapeptyl SR, with a broader indication set than the United States that includes endometriosis and uterine fibroids alongside prostate cancer and precocious puberty.
Can I buy Triptorelin in the United Kingdom?
Only with a prescription. Triptorelin is classified as "Licensed, prescription only (MHRA)" in the United Kingdom, so it is dispensed by pharmacies against a prescription for its approved indication. Buying it from unlicensed online sellers or as a "research chemical" is outside that system and carries no regulatory protection. Note: Licensed as Decapeptyl SR, with a broader indication set than the United States that includes endometriosis and uterine fibroids alongside prostate cancer and precocious puberty.
Is Triptorelin MHRA approved?
Yes, for its labeled indication. In the United Kingdom Triptorelin is classified as "Licensed, prescription only (MHRA)". For comparison, the US FDA status is: FDA-approved. Trelstar under NDA 020715 on 15 June 2000 for palliative treatment of advanced prostate cancer, with additional formulations approved in 2001 and 2010. Triptodur under NDA 208956 on 29 June 2017 for central precocious puberty in children aged two and older. Not approved in the United States for endometriosis, for fertility protocols, or for any use in healthy adults.. On the evidence, 4 human studies are cited on its profile.
Related compounds in the United Kingdom
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Triptorelin live on its compound profile.
Triptorelin profileThis page is general information about the regulatory status of Triptorelin in the United Kingdom, current as of Sep 2026. It is not legal advice, and classifications change; check Medicines and Healthcare products Regulatory Agency directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.